NO924672L - Metode for fremstilling av interferon alfa-2-krystaller - Google Patents

Metode for fremstilling av interferon alfa-2-krystaller

Info

Publication number
NO924672L
NO924672L NO92924672A NO924672A NO924672L NO 924672 L NO924672 L NO 924672L NO 92924672 A NO92924672 A NO 92924672A NO 924672 A NO924672 A NO 924672A NO 924672 L NO924672 L NO 924672L
Authority
NO
Norway
Prior art keywords
crystals
interferon alfa
preparing interferon
preparing
alfa
Prior art date
Application number
NO92924672A
Other languages
English (en)
Norwegian (no)
Other versions
NO924672D0 (no
Inventor
Paul Reichert
Gerald S Hammond
Hung V Le
Tattanahali L Nagabhushan
Paul P Trotta
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO924672D0 publication Critical patent/NO924672D0/no
Publication of NO924672L publication Critical patent/NO924672L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
NO92924672A 1990-06-04 1992-12-03 Metode for fremstilling av interferon alfa-2-krystaller NO924672L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53322590A 1990-06-04 1990-06-04
PCT/US1991/003660 WO1991018927A1 (en) 1990-06-04 1991-06-03 Method for preparing interferon alpha-2 crystals

Publications (2)

Publication Number Publication Date
NO924672D0 NO924672D0 (no) 1992-12-03
NO924672L true NO924672L (no) 1992-12-03

Family

ID=24125036

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92924672A NO924672L (no) 1990-06-04 1992-12-03 Metode for fremstilling av interferon alfa-2-krystaller

Country Status (24)

Country Link
US (2) US5460956A (pl)
EP (1) EP0597851B1 (pl)
JP (1) JPH0749440B2 (pl)
CN (2) CN1033035C (pl)
AT (1) ATE149523T1 (pl)
AU (1) AU636043B2 (pl)
CA (1) CA2084406A1 (pl)
DE (1) DE69125035T2 (pl)
ES (1) ES2098358T3 (pl)
FI (1) FI925515A7 (pl)
HU (1) HUT63185A (pl)
IE (1) IE911892A1 (pl)
IL (1) IL98354A0 (pl)
MX (1) MX9203319A (pl)
MY (1) MY107450A (pl)
NO (1) NO924672L (pl)
NZ (1) NZ238384A (pl)
OA (1) OA09720A (pl)
PL (1) PL166045B1 (pl)
PT (1) PT97849A (pl)
SG (1) SG45207A1 (pl)
TW (1) TW342395B (pl)
WO (1) WO1991018927A1 (pl)
ZA (1) ZA914200B (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5912015A (en) * 1992-03-12 1999-06-15 Alkermes Controlled Therapeutics, Inc. Modulated release from biocompatible polymers
US5711968A (en) * 1994-07-25 1998-01-27 Alkermes Controlled Therapeutics, Inc. Composition and method for the controlled release of metal cation-stabilized interferon
SE9302278D0 (sv) * 1992-10-28 1993-07-02 Kabi Pharmacia Ab Growth hormone
US5441734A (en) * 1993-02-25 1995-08-15 Schering Corporation Metal-interferon-alpha crystals
AU706180B2 (en) * 1994-07-25 1999-06-10 Alkermes Controlled Therapeutics, Inc. Controlled release of metal cation-stabilized interferon
WO1997007788A2 (en) * 1995-08-31 1997-03-06 Alkermes Controlled Therapeutics, Inc. Composition for sustained release of an agent
US5972331A (en) * 1995-12-22 1999-10-26 Schering Corporation Crystalline interferon alpha for pulmonary delivery and method for producing the same
US6392069B2 (en) 1996-01-08 2002-05-21 Canji, Inc. Compositions for enhancing delivery of nucleic acids to cells
US20100251425A9 (en) * 1998-05-15 2010-09-30 University Of Central Florida Expression of human interferon in transgenic chloroplasts
US6281337B1 (en) 1998-11-12 2001-08-28 Schering Corporation Methods for conversion of protein isoforms
DE19859876A1 (de) 1998-12-23 2000-06-29 Fraunhofer Ges Forschung Verfahren zur Kristallisation aus Lösungen
US6465425B1 (en) 2000-02-10 2002-10-15 Alkermes Controlled Therapeutics, Inc. Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins
BRPI0213564B8 (pt) * 2001-10-30 2021-05-25 Novartis Ag formulação depósito e micropartícula compreendendo iloperidona e polímero poli(d,l-lactídeo-co-glicolídeo), e processo para preparação da referida micropartícula
GB0216416D0 (en) 2002-07-15 2002-08-21 Novartis Ag Organic compounds
DE60332358D1 (de) * 2002-09-09 2010-06-10 Hanall Pharmaceutical Co Ltd Protease-resistente modifizierte interferon alpha polypeptide
RU2357750C2 (ru) 2002-12-31 2009-06-10 Элтус Фармасьютикалз Инк. Кристаллы человеческого гормона роста и способы их получения
JP2006523609A (ja) * 2002-12-31 2006-10-19 アルタス ファーマシューティカルズ インコーポレイテッド タンパク質結晶およびイオン性ポリマーの複合体
BRPI0507169A (pt) 2004-02-02 2007-06-26 Ambrx Inc polipeptìdeos do hormÈnio de crescimento humano modificados e seu usos
US8679472B1 (en) 2006-10-05 2014-03-25 Merck, Sharp & Dohme Corp. Crystal of human interferon alpha 2B in complex with zinc
MX344166B (es) 2008-02-08 2016-12-07 Ambrx Inc Leptina-polipeptidos modificados y sus usos.
EP2459211A1 (en) 2009-07-31 2012-06-06 Medtronic, Inc. Continuous subcutaneous administration of interferon- to hepatitis c infected patients
EP3079668A1 (en) 2013-12-09 2016-10-19 Durect Corporation Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2882203A (en) * 1951-06-26 1959-04-14 Novo Terapeutisk Labor As Injectable insulin preparation with protracted effect
US2822203A (en) * 1955-02-17 1958-02-04 Gen Motors Corp Door latch and control means
US4315852A (en) * 1980-11-26 1982-02-16 Schering Corporation Extraction of interferon from bacteria
US4672108A (en) * 1981-12-07 1987-06-09 Hoffmann-La Roche Inc. Crystalline human leukocyte interferon
US4853218A (en) * 1987-02-24 1989-08-01 Schering Corporation Zinc-protamine-alpha interferon complex
US5441734A (en) * 1993-02-25 1995-08-15 Schering Corporation Metal-interferon-alpha crystals

Also Published As

Publication number Publication date
CA2084406A1 (en) 1991-12-05
ES2098358T3 (es) 1997-05-01
US5460956A (en) 1995-10-24
NO924672D0 (no) 1992-12-03
DE69125035D1 (de) 1997-04-10
US5741485A (en) 1998-04-21
HU9203828D0 (en) 1993-03-29
IE911892A1 (en) 1991-12-04
NZ238384A (en) 1992-11-25
ATE149523T1 (de) 1997-03-15
OA09720A (en) 1993-08-30
IL98354A0 (en) 1992-07-15
FI925515L (fi) 1992-12-04
HUT63185A (en) 1993-07-28
MY107450A (en) 1995-12-30
AU7955291A (en) 1991-12-31
CN1033035C (zh) 1996-10-16
SG45207A1 (en) 1998-01-16
AU636043B2 (en) 1993-04-08
JPH0749440B2 (ja) 1995-05-31
CN1044709C (zh) 1999-08-18
DE69125035T2 (de) 1997-07-10
CN1132212A (zh) 1996-10-02
EP0597851A1 (en) 1994-05-25
JPH05503292A (ja) 1993-06-03
TW342395B (en) 1998-10-11
EP0597851B1 (en) 1997-03-05
CN1058022A (zh) 1992-01-22
MX9203319A (es) 1992-07-31
PL166045B1 (pl) 1995-03-31
FI925515A0 (fi) 1992-12-04
WO1991018927A1 (en) 1991-12-12
ZA914200B (en) 1992-03-25
PT97849A (pt) 1992-03-31
FI925515A7 (fi) 1992-12-04

Similar Documents

Publication Publication Date Title
NO924672L (no) Metode for fremstilling av interferon alfa-2-krystaller
BG41820A3 (en) Method for preparing n- (3- hydroxy- 4- piperidinyl) benzamide derivatives
BG40654A3 (bg) Метод за получаване на циклоалкилтриазоли
EP0129778A3 (en) Cell-stimulating composition
BG37995A3 (en) Method for preparing derivatives of 2- cyanbenzimidazol
DE19475021I2 (de) Naphthochinonderivate
BG38334A3 (en) Method for preparing pyrolidinic derivatives
BG35328A3 (en) Method for preparing imidodisulphamidic derivatives
BG36348A3 (en) Method for preparing thienopyridinon derivatives
BG36932A3 (bg) Метод за получаване на 1-(3-хидрокси-4-метаксибензоил)-3- хидрокси-2-пиролидинон
BG40803A3 (bg) Метод за получаване на арилциклобутилалкиламинови производни
BG38638A3 (bg) Метод за получаване на арилциклобутил-аминопроизводни
ES2039217T3 (es) Nuevos derivados de 3 - aril - 3 - cicloalquil - piperidin 2,6 - diona.
BG38637A3 (en) Method for preparing 2- exo- hydroxy- 7- oxabicyclo [2, 2, 1] heptanes
BG32116A3 (bg) Метод за получаване на 4''-амино-олеандомицинови производни
BG37840A3 (bg) Метод за получаване на производни на ортокондензиран пирол
BG38338A3 (en) Method for preparing 6 alpha- methylhydrocortisonic derivatives
BG40143A3 (en) Method for preparing acetamide derivatives
ES464764A1 (es) Un procedimiento para preparar un compuesto de indol-dihi- droindoldionadimerico
BG36347A3 (en) Method for preparing thienopyridinon derivatives
BG35895A3 (en) Method for preparing of n- substituted- 2- haloacetanilides
BG35044A3 (bg) Метод за получаване на 1-окса-бета-лактамови антибиотици
JPS545934A (en) 4-(4'-alkoxybenzoyloxy)-aniline derivatives, process for their preparation and their use
BG42001A3 (en) Method for preparing of 1- aryl- 2- aminoethanol derivatives
BG36634A3 (bg) Метод за получаване на о-арил-n-фосфонометилглицинонитрили